Abstract:Aims: Hyperlipidemia-induced oxidative stress is considered to be one of the main pathogenic factors that contribute to pancreatic beta cell dysfunction in the development of type 2 diabetes (T2D). Sirtuin 3 (Sirt3) is abundantly expressed in the mitochondria as an NAD+-dependent deacetylase and regulates mitochondrial adaptive responses to oxidative stress. We examined the antioxidant defense mechanism of Sirt3 in pancreatic beta cells in the context of hyperlipidemia. Results: Chronic high-fat diet (HFD) feeding caused elevated oxidative stress accompanied by reduced Sirt3 expression in the pancreatic beta cells of wild-type mice. Primary pancreatic islets of Sirt3 knockout (KO) mice and murine pancreatic MIN6 cells with downregulated Sirt3 expression showed increased superoxide dismutase 2 (SOD2) acetylation and reduced glucose-stimulated insulin secretion and glucose-stimulated adenosine triphosphate (ATP) generation. Moreover, Sirt3 deficiency sensitized the pancreatic islets and MIN6 cells to palmitate- and H2O2-induced beta cell dysfunction linked with aggravated c-Jun N-terminal kinase phosphorylation and cleaved caspase-3 expression. These negative effects were reversed by antioxidant chemical treatment or restoration of Sirt3 in KO islets. Finally, overexpression of Sirt3 in MIN6 cells partially rescued palmitate-induced reactive oxygen species generation, pancreatic and duodenal homeobox-1 (Pdx-1) nucleo-cytoplasmic translocation, and beta cell dysfunction. Innovation: We present that Sirt3 expression protected pancreatic beta cells from lipotoxicity by antagonizing oxidative stress-induced cell damage. Conclusion: These results suggest that Sirt3 may be a target for amelioration of beta cell dysfunction due to obesity and T2D. Antioxid. Redox Signal. 27, 962-976.

Hepatic Sirt1 Deficiency in Mice Impairs Mtorc2/akt Signaling and Results in Hyperglycemia, Oxidative Damage, and Insulin Resistance.

Sirt1 Mediates Vitamin D Deficiency-Driven Gluconeogenesis in the Liver via mTorc2/Akt Signaling

Sirt6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-Stimulated Glucose Uptake in Mice

Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence

Knockdown of Sirt1 Gene in Mice Results in Lipid Accumulation in the Liver Mediated via PGC-1α-Induced Mitochondrial Dysfunction and Oxidative Stress

SIRT1 Attenuates High Glucose-Induced Insulin Resistance Via Reducing Mitochondrial Dysfunction in Skeletal Muscle Cells.

Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function Without Development of Hyperglycemia.

1806-P: Vitamin D Deficiency Impairs mTORC2/Akt Signaling through Downregulating SIRT1 and Results in Increased Hepatic Gluconeogenesis

Sirt3 Deficiency Increased the Vulnerability of Pancreatic Beta Cells to Oxidative Stress-Induced Dysfunction

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

Lack of SIRT1 (mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1+/- Mice: a Role of Lipid Mobilization and Inflammation.

Sirt1-PPARS Cross-Talk in Complex Metabolic Diseases and Inherited Disorders of the One Carbon Metabolism

Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β Cells

Hepatic-Specific Disruption of Sirt6 in Mice Results in Fatty Liver Formation Due to Enhanced Glycolysis and Triglyceride Synthesis

Adipose-specific Knockdown of Sirt1 Results in Obesity and Insulin Resistance by Promoting Exosomes Release

Sirt 1 Decreased Adipose Inflammation by Interacting with Akt 2 and Inhibiting Mtor / S 6 K 1 Pathway in Mice

Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function

The role of NAD-dependent deacetylase sirtuin-2 in liver metabolic stress through regulating pyruvate kinase M2 ubiquitination

SIRT1 enhances glucose tolerance by potentiating brown adipose tissue function

SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase

SIRT2 ablation inhibits glucose-stimulated insulin secretion through decreasing glycolytic flux